Sunnylife Pharma

Sunnylife Pharma Overview

Founded 2012
Status Private
Employees 3
Latest Deal Type Grant
Latest Deal Amount $275K
Latest Deal Amount
Investors 2

Sunnylife Pharma General Information


Operator of a drug delivery and delivery company intended to provide therapeutics for a variety of conditions and diseases that present a threat to human life. The company provides small molecules for therapeutic, called HPV vaccines used in the areas of cancer, virology, cardiovascular and metabolic diseases to block the activity of an HPV-specific protein, enabling patients to prevent infection and get rid of cancer.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Primary Industry
Drug Discovery
Other Industries
Drug Delivery
Primary Office
  • 5225 Exploration Drive
  • Indianapolis, IN 46241
  • United States
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Sunnylife Pharma Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Grant 01-Jan-2016 $275K Completed Startup
1. Accelerator/Incubator Completed Startup

Sunnylife Pharma Executive Team (3)

Name Title Board Seat Contact Info
Zhijian Lu Ph.D Chief Executive Officer
Xibin Liao Ph.D Co-Founder & General Manager
Alison Strack Ph.D Chief Scientific Officer

Sunnylife Pharma Investors (2)

To view Sunnylife Pharma‘s full investor history, request access »
Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
National Science Foundation Government 000 0000 000000 0
Purdue Research Foundation Limited Partner Minority 000 0000 000000 0

Ready to get started?

Request a free trial